Search | TVST | ARVO Journals

Showing 1 – 17 of 17

SORT: Best Match Most Recent Oldest

VIEW: Basic | Expanded

ARVO Annual Meeting Abstract June 2024

Sub-retinal gene therapy improves function and structure in patients with Bothnia Dystrophy

Nalini Rangaswamy; Karen Holopigian; Christine Watters; Anders P Kvanta; Sofie Westman; Kalliopi Stasi; Helder Andre; Melissa Liew

Invest. Ophthalmol. Vis. Sci.. 2024; 65(7):2135.

Retina October 2023

Retinal Dystrophy Associated With RLBP1 Retinitis Pigmentosa: A Five-Year Prospective Natural History Study

PDF

Marie Burstedt; James H. Whelan; Jane S. Green; Karen Holopigian; Claudio Spera; Erin Greco; Jean-Yves Deslandes; Michael Wald; Cynthia Grosskreutz; Xiao Ni; Guillaume Normand; Michael Maker; Arnaud Charil; Michael Rosol; Yunsheng He; Kalliopi Stasi
TAGS: disease progression, eye, natural history, retinal dystrophies, retinitis pigmentosa, surrogate endpoints, vision, mutation, wavelength
Invest. Ophthalmol. Vis. Sci.. 2023; 64(13):42. https://doi.org/10.1167/iovs.64.13.42

Includes: Supplemental Content

Cornea & External Disease September 2023

Ocular Pharmacology and Toxicology of TRPV1 Antagonist SAF312 (Libvatrep)

PDF

Muneto Mogi; Anisha E. Mendonza; James Chastain; John T. Demirs; Quintus G. Medley; Qin Zhang; Julien P. N. Papillon; Junzheng Yang; Yan Gao; YongYao Xu; Kalliopi Stasi
TAGS: cornea, ocular surfaces, pain, pharmacology, toxicology, transient receptor potential v1 antagonists, trpv1 receptor, wound healing, oryctolagus cuniculus, keratectomy
Trans. Vis. Sci. Tech.. 2023; 12(9):5. https://doi.org/10.1167/tvst.12.9.5

Includes: Supplemental Content

Cornea & External Disease March 2023

Topical Ocular TRPV1 Antagonist SAF312 (Libvatrep) for Postoperative Pain After Photorefractive Keratectomy

PDF

Vance Thompson; Majid Moshirfar; Thomas Clinch; Stephen Scoper; Steven H. Linn; Avery McIntosh; Yifang Li; Matt Eaton; Michael Ferriere; Kalliopi Stasi
TAGS: keratectomy, pain, postoperative pain, transient receptor potential v1 antagonists, eye, surrogate endpoints
Trans. Vis. Sci. Tech.. 2023; 12(3):7. https://doi.org/10.1167/tvst.12.3.7

Includes: Supplemental Content

Cornea & External Disease November 2022

Topical Ocular TRPV1 Antagonist SAF312 (Libvatrep) Demonstrates Safety, Low Systemic Exposure, and No Anesthetic Effect in Healthy Participants

PDF

Kalliopi Stasi; Qusai Alshare; Monish Jain; Michael Wald; Yifang Li
TAGS: anesthetics, cornea, safety, transient receptor potential v1 antagonists
Trans. Vis. Sci. Tech.. 2022; 11(11):15. https://doi.org/10.1167/tvst.11.11.15

Includes: Supplemental Content

ARVO Annual Meeting Abstract June 2021

Topical ocular TRPV1 antagonist SAF312 was well tolerated and effectively reduced pain after photorefractive keratectomy (PRK)

Kalliopi Stasi; Vance Thompson; Majid Moshirfar; Thomas Clinch; Stephen Scoper; Steven Linn; Avery McIntosh; Yifang Li; Matt Eaton; Michela Montecchi Palmer; Sameena Haque; Michael Ferriere

Invest. Ophthalmol. Vis. Sci.. 2021; 62(8):967.

ARVO Annual Meeting Abstract June 2021

Topical ocular TRPV1 antagonist SAF312 demonstrated safety, low systemic exposure, and no anesthetic effect in healthy volunteers

Yifang Li; Monish Jain; Michela Montecchi Palmer; Sameena Haque; Kalliopi Stasi

Invest. Ophthalmol. Vis. Sci.. 2021; 62(8):725.

ARVO Annual Meeting Abstract June 2017

Central visual function over two-year follow-up of patients with RLBP1 retinitis pigmentosa enrolled in a prospective Natural History Study

Kalliopi Stasi; Michael Wald; Marie Burstedt; Jane Green; James Whelan; Michael Rosol; Xiao Ni; Zhenzhong Su; Jean-Yves Deslandes; Cynthia L Grosskreutz; Karen Holopigian

Invest. Ophthalmol. Vis. Sci.. 2017; 58(8):3244.

ARVO Annual Meeting Abstract June 2017

Humphrey visual field and flicker electroretinogram changes over two-year follow-up in patients with RLBP1 retinitis pigmentosa enrolled in a prospective Natural History Study

Karen Holopigian; Jane Green; James Whelan; Marie Burstedt; Zhenzhong Su; Jean-Yves Deslandes; Xiao Ni; Michael Wald; Cynthia L Grosskreutz; Kalliopi Stasi

Invest. Ophthalmol. Vis. Sci.. 2017; 58(8):3246.

ARVO Annual Meeting Abstract June 2017

Full-field stimulus threshold dark-adaptation kinetics over two-year follow-up in patients with RLBP1 retinitis pigmentosa enrolled in a prospective Natural History Study

Xiao Ni; Michael Wald; Marie Burstedt; Jane Green; James Whelan; Zhenzhong Su; Jean-Yves Deslandes; Cynthia L Grosskreutz; Kalliopi Stasi; Karen Holopigian

Invest. Ophthalmol. Vis. Sci.. 2017; 58(8):3249.

ARVO Annual Meeting Abstract June 2017

Cross-sectional evaluation of patient-reported outcomes (PROs) in patients with RLBP1 retinitis pigmentosa enrolled in a Natural History Study

Anmol Mullins; Marie Burstedt; Jane Green; James Whelan; Brigitte Sloesen; Xiao Ni; Zhenzhong Su; Michael Wald; Cynthia L Grosskreutz; Kalliopi Stasi; Karen Holopigian; Jean-Yves Deslandes

Invest. Ophthalmol. Vis. Sci.. 2017; 58(8):3251.

ARVO Annual Meeting Abstract June 2017

Baseline characteristics of patients with RLBP1 retinitis pigmentosa enrolled in a prospective Natural History Study

Jane Green; Marie Burstedt; James H Whelan; Yunsheng He; Zhenzhong Su; Xiao Ni; Michael Wald; Guillaume Normand; Jean-Yves Deslandes; Cynthia L Grosskreutz; Karen Holopigian; Kalliopi Stasi

Invest. Ophthalmol. Vis. Sci.. 2017; 58(8):3254.

ARVO Annual Meeting Abstract June 2017

Longitudinal evaluation of optical coherence tomography and color fundus photography over 2 year follow up in patients with RLBP1 retinitis pigmentosa

James H Whelan; Guillaume Normand; Michael Maker; Marie Burstedt; Jane Green; Michael Wald; Zhenzhong Su; Xiao Ni; Karen Holopigian; Cynthia L Grosskreutz; Kalliopi Stasi

Invest. Ophthalmol. Vis. Sci.. 2017; 58(8):3255.

Nantotechnology and Regenerative Medicine January 2014

Optimal Isolation and Xeno-Free Culture Conditions for Limbal Stem Cell Function

PDF

Kalliopi Stasi; DaVida Goings; Jiayan Huang; Lindsay Herman; Filipa Pinto; Russell C. Addis; Dahlia Klein; Giacomina Massaro-Giordano; John D. Gearhart
TAGS: epithelial cells, immunocytochemistry, patient isolation, reverse transcriptase polymerase chain reaction, social isolation, stem cells, calcium, magnetic resonance cholangiography, dissociation, medical reserve corps
Invest. Ophthalmol. Vis. Sci.. 2014; 55(1):375-386. https://doi.org/10.1167/iovs.13-12517

Includes: Supplemental Content

ARVO Annual Meeting Abstract June 2013

Comparison of Human and Mouse Feeders, Xeno-free and Standard Media in Different Oxygen Tensions for Preservation of Human Limbal Progenitor Cells during Culture

Kalliopi Stasi; Mina Massaro-Giordano; Jiayan Huang; John Gearhart

Invest. Ophthalmol. Vis. Sci.. 2013; 54(15):1004.

Glaucoma February 2007

Ceruloplasmin Upregulation in Retina of Murine and Human Glaucomatous Eyes

PDF

Kalliopi Stasi; Dalia Nagel; Xiaoyan Yang; Lizhen Ren; Thom Mittag; John Danias
TAGS: ceruloplasmin, eye, glaucoma, retina, up-regulation (physiology), mice, immunohistochemistry, proteins, body tissue, immunoblotting
Invest. Ophthalmol. Vis. Sci.. 2007; 48(2):727-732. https://doi.org/10.1167/iovs.06-0497

Glaucoma March 2006

Complement Component 1Q (C1Q) Upregulation in Retina of Murine, Primate, and Human Glaucomatous Eyes

PDF

Kalliopi Stasi; Dalia Nagel; Xiaoyan Yang; Rong-Fang Wang; Lizhen Ren; Steven M. Podos; Thom Mittag; John Danias
TAGS: complement c1q, eye, glaucoma, mice, primates, retina, up-regulation (physiology), immunohistochemistry, immunoblotting, proteins
Invest. Ophthalmol. Vis. Sci.. 2006; 47(3):1024-1029. https://doi.org/10.1167/iovs.05-0830

NARROW

Content Type

Journal

Article Type

Topics

Tags

Specify Date Range

Sub-retinal gene therapy improves function and structure in patients with Bothnia Dystrophy

Retinal Dystrophy Associated With RLBP1 Retinitis Pigmentosa: A Five-Year Prospective Natural History Study

Ocular Pharmacology and Toxicology of TRPV1 Antagonist SAF312 (Libvatrep)

Topical Ocular TRPV1 Antagonist SAF312 (Libvatrep) for Postoperative Pain After Photorefractive Keratectomy

Topical Ocular TRPV1 Antagonist SAF312 (Libvatrep) Demonstrates Safety, Low Systemic Exposure, and No Anesthetic Effect in Healthy Participants

Topical ocular TRPV1 antagonist SAF312 was well tolerated and effectively reduced pain after photorefractive keratectomy (PRK)

Topical ocular TRPV1 antagonist SAF312 demonstrated safety, low systemic exposure, and no anesthetic effect in healthy volunteers

Central visual function over two-year follow-up of patients with RLBP1 retinitis pigmentosa enrolled in a prospective Natural History Study

Humphrey visual field and flicker electroretinogram changes over two-year follow-up in patients with RLBP1 retinitis pigmentosa enrolled in a prospective Natural History Study

Full-field stimulus threshold dark-adaptation kinetics over two-year follow-up in patients with RLBP1 retinitis pigmentosa enrolled in a prospective Natural History Study

Cross-sectional evaluation of patient-reported outcomes (PROs) in patients with RLBP1 retinitis pigmentosa enrolled in a Natural History Study

Baseline characteristics of patients with RLBP1 retinitis pigmentosa enrolled in a prospective Natural History Study

Longitudinal evaluation of optical coherence tomography and color fundus photography over 2 year follow up in patients with RLBP1 retinitis pigmentosa

Optimal Isolation and Xeno-Free Culture Conditions for Limbal Stem Cell Function

Comparison of Human and Mouse Feeders, Xeno-free and Standard Media in Different Oxygen Tensions for Preservation of Human Limbal Progenitor Cells during Culture

Ceruloplasmin Upregulation in Retina of Murine and Human Glaucomatous Eyes

Complement Component 1Q (C1Q) Upregulation in Retina of Murine, Primate, and Human Glaucomatous Eyes

To View More...

You must be signed into an individual account to use this feature.